260 related articles for article (PubMed ID: 34446027)
21. Meta-Analysis of HTLV-1-Infected Patients Identifies CD40LG and GBP2 as Markers of ATLL and HAM/TSP Clinical Status: Two Genes Beat as One.
Fukutani ER; Ramos PIP; Kasprzykowski JI; Azevedo LG; Rodrigues MMS; Lima JVOP; de Araújo Junior HFS; Fukutani KF; de Queiroz ATL
Front Genet; 2019; 10():1056. PubMed ID: 31781157
[TBL] [Abstract][Full Text] [Related]
22. High IFN-γ/IL-10 expression ratio and increased frequency of persistent human T-cell lymphotropic virus type 1-infected clones are associated with human T-cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis development.
Espíndola OM; Oliveira LC; Ferreira PM; Leite AC; Lima MA; Andrada-Serpa MJ
Intervirology; 2015; 58(2):106-14. PubMed ID: 25833232
[TBL] [Abstract][Full Text] [Related]
23. Quantitative differences in HTLV-I antibody responses: classification and relative risk assessment for asymptomatic carriers and ATL and HAM/TSP patients from Jamaica.
Enose-Akahata Y; Abrams A; Johnson KR; Maloney EM; Jacobson S
Blood; 2012 Mar; 119(12):2829-36. PubMed ID: 22318200
[TBL] [Abstract][Full Text] [Related]
24. Following the Clues: Usefulness of Biomarkers of Neuroinflammation and Neurodegeneration in the Investigation of HTLV-1-Associated Myelopathy Progression.
Souza FDS; Freitas NL; Gomes YCP; Torres RC; Echevarria-Lima J; da Silva-Filho IL; Leite ACCB; de Lima MASD; da Silva MTT; Araújo AQC; Espíndola OM
Front Immunol; 2021; 12():737941. PubMed ID: 34764955
[TBL] [Abstract][Full Text] [Related]
25. The effect of HTLV-1 virulence factors (HBZ, Tax, proviral load), HLA class I and plasma neopterin on manifestation of HTLV-1 associated myelopathy tropical spastic paraparesis.
Tarokhian H; Taghadosi M; Rafatpanah H; Rajaei T; Azarpazhooh MR; Valizadeh N; Rezaee SAR
Virus Res; 2017 Jan; 228():1-6. PubMed ID: 27845163
[TBL] [Abstract][Full Text] [Related]
26. Decrease in naïve T cell production due to HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) development.
Gomes JAN; da Silva Dias GA; Fujihara S; Yoshikawa GT; Koyama RVL; Sousa RCM; Quaresma JAS; Fuzii HT
Immunobiology; 2021 Jan; 226(1):152050. PubMed ID: 33338979
[TBL] [Abstract][Full Text] [Related]
27. Hodgkin-like adult T-cell leukemia/lymphoma that developed during the follow-up of HTLV-1 associated myelopathy/tropical spastic paraparesis.
Nakaya Y; Yoshida M; Tsutsumi M; Fuseya H; Horiuchi M; Yoshimura T; Hayashi Y; Nakao T; Koh KR; Niino D; Inoue T; Yamane T
J Clin Exp Hematop; 2019 Sep; 59(3):130-134. PubMed ID: 31391405
[TBL] [Abstract][Full Text] [Related]
28. The IL-18, IL-12, and IFN-γ expression in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients, HTLV-1 carriers, and healthy subjects.
Bidkhori HR; Hedayati-Moghaddam MR; Mosavat A; Valizadeh N; Tadayon M; Ahmadi Ghezeldasht S; Rafatpanah H; Rezaee SA
J Neurovirol; 2020 Jun; 26(3):338-346. PubMed ID: 32270468
[TBL] [Abstract][Full Text] [Related]
29. Lessons from the Cerebrospinal Fluid Analysis of HTLV-1-Infected Individuals: Biomarkers of Inflammation for HAM/TSP Development.
Freitas NL; Gomes YCP; Souza FDS; Torres RC; Echevarria-Lima J; Leite ACCB; Lima MASD; Araújo AQC; Silva MTT; Espíndola OM
Viruses; 2022 Sep; 14(10):. PubMed ID: 36298702
[TBL] [Abstract][Full Text] [Related]
30. Frequency of p12K and p12R alleles of HTLV Type 1 in HAM/TSP patients and in asymptomatic HTLV type 1 carriers.
Martins ML; Soares BC; Ribas JG; Thorun GW; Johnson J; Kroon EG; Carneiro-Prioetti AB; Bonjardim CA;
AIDS Res Hum Retroviruses; 2002 Sep; 18(13):899-902. PubMed ID: 12230932
[TBL] [Abstract][Full Text] [Related]
31. Co-presentation of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis and adult-onset infective dermatitis associated with HTLV-1 infection.
Okajima R; Casseb J; Sanches JA
Int J Dermatol; 2013 Jan; 52(1):63-8. PubMed ID: 23278610
[TBL] [Abstract][Full Text] [Related]
32. The human T-cell leukemia virus type 1 (HTLV-1): new insights into the clinical aspects and molecular pathogenesis of adult T-cell leukemia/lymphoma (ATLL) and tropical spastic paraparesis/HTLV-associated myelopathy (TSP/HAM).
Shuh M; Beilke M
Microsc Res Tech; 2005 Nov; 68(3-4):176-96. PubMed ID: 16276549
[TBL] [Abstract][Full Text] [Related]
33. Differential modulation of IL-4, IL-10, IL-17, and IFN-γ production mediated by IgG from Human T-lymphotropic virus-1 (HTLV-1) infected patients on healthy peripheral T (CD4+, CD8+, and γδ) and B cells.
Machado NR; Fagundes BO; Fernandes LA; de Oliveira ACP; Nukui Y; Casseb J; Cunha FRM; Nali LHDS; Sanabani SS; Victor JR
Front Med (Lausanne); 2023; 10():1239706. PubMed ID: 37711742
[TBL] [Abstract][Full Text] [Related]
34. Altered expression of degranulation-related genes in CD8+ T cells in human T lymphotropic virus type I infection.
Malta TM; Silva IT; Pinheiro DG; Santos AR; Pinto MT; Panepucci RA; Takayanagui OM; Tanaka Y; Covas DT; Kashima S
AIDS Res Hum Retroviruses; 2013 May; 29(5):826-36. PubMed ID: 23301858
[TBL] [Abstract][Full Text] [Related]
35. Human T cell lymphotropic virus type 1 (HTLV-1) proviral load of HTLV-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients according to new diagnostic criteria of HAM/TSP.
Grassi MF; Olavarria VN; Kruschewsky Rde A; Mascarenhas RE; Dourado I; Correia LC; de Castro-Costa CM; Galvão-Castro B
J Med Virol; 2011 Jul; 83(7):1269-74. PubMed ID: 21567429
[TBL] [Abstract][Full Text] [Related]
36. SYBR Green-based quantitation of human T-lymphotropic virus type 1 proviral load in Peruvian patients with neurological disease and asymptomatic carriers: influence of clinical status, sex, and familial relatedness.
Adaui V; Verdonck K; Best I; González E; Tipismana M; Arévalo J; Vanham G; Campos M; Zimic M; Gotuzzo E
J Neurovirol; 2006 Dec; 12(6):456-65. PubMed ID: 17162661
[TBL] [Abstract][Full Text] [Related]
37. An altered maturation and adhesion phenotype of dendritic cells in diseased individuals compared to asymptomatic carriers of human T cell leukemia virus type 1.
Manuel SL; Sehgal M; Khan ZK; Goedert JJ; Betts MR; Jain P
AIDS Res Hum Retroviruses; 2013 Sep; 29(9):1273-85. PubMed ID: 23750452
[TBL] [Abstract][Full Text] [Related]
38. Effects of host restriction factors and the HTLV-1 subtype on susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis.
Nozuma S; Matsuura E; Kodama D; Tashiro Y; Matsuzaki T; Kubota R; Izumo S; Takashima H
Retrovirology; 2017 Apr; 14(1):26. PubMed ID: 28420387
[TBL] [Abstract][Full Text] [Related]
39. Higher expression of BRCA1, and CHUK and lower expression of NFKBIA, ESR1, PIK3R1, and PPARG in HAM/TSP compared to ATLL, a diverse pathological consequence.
Yaslianifard S; Movahedi M; Yaslianifard S; Mozhgani SH
Indian J Pathol Microbiol; 2024 Jun; ():. PubMed ID: 38847220
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of ABL1 tyrosine kinase reduces HTLV-1 proviral loads in peripheral blood mononuclear cells from patients with HTLV-1-associated myelopathy/tropical spastic paraparesis.
Kodama D; Tanaka M; Matsuzaki T; Izumo K; Nakano N; Matsuura E; Saito M; Nagai M; Horiuchi M; Utsunomiya A; Takashima H; Kubota R; Izumo S
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008361. PubMed ID: 32667912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]